Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association

Circulation. 2015 Mar 24;131(12):1123-49. doi: 10.1161/CIR.0000000000000183. Epub 2015 Feb 23.

Authors

Jeffrey B Washam, Charles A Herzog, Amber L Beitelshees, Mauricio G Cohen, Timothy D Henry, Navin K Kapur, Jessica L Mega, Venu Menon, Robert L Page 2nd, L Kristin Newby; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, Council on the Kidney in Cardiovascular Disease, and Council on Quality of Care and Outcomes Research

PMID: 25712269
DOI: 10.1161/CIR.0000000000000183

No abstract available

Keywords: AHA Scientific Statements; acute coronary syndrome; chronic kidney disease; kidney disease; pharmacotherapy.

Publication types

Review

MeSH terms

Acute Coronary Syndrome / diagnosis
Acute Coronary Syndrome / drug therapy*
Acute Coronary Syndrome / epidemiology*
American Heart Association*
Cardiovascular Agents / therapeutic use*
Humans
Renal Insufficiency, Chronic / diagnosis
Renal Insufficiency, Chronic / drug therapy*
Renal Insufficiency, Chronic / epidemiology*
United States

Substances

Cardiovascular Agents